Bilowgii sanadkan, Shanghai Pudong New Area ayaa sii daayay qorshe hawleed loogu talagalay horumarinta tayada sare leh ee warshadaha biopharmaceutical, iyada oo ujeedadu tahay in kor loo qaado miisaanka warshadaha biopharmaceutical si loo gaaro calaamadda 400 ee yuan iyada oo loo marayo hal-abuurnimo hay'ad.In la dhiso saldhig warshadeed istaraatijiyadeed oo heer qaran ah iyo koox wax soo saar horumarsan oo heerkeedu dhan yahay 100 bilyan.Waxaa lagu qiyaasaa in sanadka 2025, miisaanka daawada cusub iyo warshadaha caafimaadka nolosha ay kor u dhaafi doonaan 540 bilyan yuan;"Qorshaha Hirgelinta Gobolka Fujian ee Dardargelinta Horumarinta Tayada Sare ee Warshadaha Biomedical" waxay soo jeedinaysaa, Laga bilaabo 2022 ilaa 2025, waxaa la qorsheeyay in la diyaariyo fund gaar ah oo gobolka ah oo ku dhow 1 bilyan yuan si loo taageero horumarinta warshadaha biomedical.Zhang Wenyang, oo xubin ka ah kooxda xisbiga iyo agaasime ku xigeenka Guddiga Horumarinta iyo Dib-u-habaynta Gobolka Fujian, ayaa sheegay in 2025, dakhliga hawlgalka ee warshadaha dawooyinka ee gobolka uu ku dadaali doono inuu gaaro 120 bilyan yuan, abuurista koox ka mid ah shirkadaha hormuudka ah ee lafdhabarta, alaabada hal-abuurka leh ee muhiimka ah. , cilmi baarista iyo horumarinta tignoolajiyada iyo xarumaha adeegyada guud iyo warshadaha sifada ah oo kufsan. Shirkadaha caafimaadka sidaNingbo ALPSka qayb qaadan doona.
Warshadaha kobcaya ayaa soo jiita tartanka raasamaal.2021, waxaa jiri doona 121 shirkadood oo liisan cusub oo ku jira qaybta cilmiga noolaha ee dalkayga, koror sanad-sannadka ka badan 75%;ku dhawaad 1,900 oo dhacdooyin maalgelineed ayaa ka dhacay cilmiga noolaha, cadadka maalgelinta ee la shaaciyayna waxa ay gaadheen in ka badan 260 bilyan yuan.
Marka la eego siyaasadaha, tignoolajiyada, iyo raasumaalka, R&D iyo xoogga hal-abuurka ee warshadaha biopharmaceutical ayaa si joogto ah u kordhay, miisaankuna waa uu sii kordhay.Xogta laga soo xigtay Xafiiska Tirakoobka Qaranka ayaa muujineysa in sanadka 2020, cabirka suuqa ee warshadaha dawooyinka-biopharmaceutical ee dalkaygu uu gaari doono 3.57 trillion yuan, sanadba sanadka ka dambeeya kororka 8.51%.Waxaa la filayaa in ay dhaafto 4 tiriliyan yuan sanadka 2022.
Waqtiga boostada: Meey-20-2022